Reconstructive Urology FellowNHS

Job summary

We are looking to recruit a highly motivated and dedicated Clinical Fellows from January to October 2027 in the Male Reconstruction Team. This post offers an excellent opportunity for a Clinical Fellow to work within a busy, tertiary Urology service at UCLH, gaining broad clinical exposure across theatres, clinics, and inpatient care under the supervision of Consultant Urologists Daniela Andrich and Professor Anthony Mundy. The post-holder will work closely within a multidisciplinary team spanning medical, nursing, and administrative colleagues to ensure patients receive safe, timely, and effective care throughout their pathway. Alongside strong clinical duties, the post-holder expected to be actively engaged in contributing to 18-week RTT compliance and theatre list utilisation.

Main duties of the job

The Clinical Fellow will hold primary responsibility for the day-to-day care of patients admitted to the service, working closely with Consultants across ward rounds, clinics, and theatre sessions. The role offers hands-on exposure to the full patient pathway, from new referrals through to ongoing follow-up, alongside opportunities to develop operative skills under consultant supervision. Given the trauma-heavy nature of urology admissions, strong multi-disciplinary teamworking and communication skills are essential, including regular engagement with MDT meetings. The successful candidate will also contribute to audit, research, and teaching, making this a well-rounded post for someone looking to build clinical, academic, and leadership experience in equal measure. We're looking for a proactive, patient-focused doctor who thrives in a fast-paced surgical environment and is committed to continuous learning and collaborative care.

Job description

For the full Person Specification and more information regarding the main responsibilities of this role, please refer to the attached Job Description.

Please note, due to anticipated high volumes of applications, this vacancy may close earlier than the listed closing date. You are advised not to delay submitting your completed application Come and be a part of the best NHS trust in England to work for, according to our staff*

• UCLH top trust to work at in England - In the most recent NHS staff survey UCLH had the highest percentage of staff who said they would recommend us as a place to work, out of all general acute or acute/community NHS trusts in England for the third year in a row.

UCLH recognises the benefits of flexible working for staff To find out more, visit: Flexible working.

To discover more about what makes UCLH a great place to work, visit: Why Choose UCLH?

About us

University College London Hospitals NHS Foundation Trust (UCLH) is one of the most complex NHS trusts in the UK, serving a large and diverse population. We provide academically led acute and specialist services, to people from the local area, from throughout the United Kingdom and overseas. Our vision is to deliver top-quality patient care, excellent education, and world-class research.

We provide first-class acute and specialist services across eight sites:o University College Hospital (incorporating the Elizabeth Garrett Anderson Wing)o National Hospital for Neurology and Neurosurgeryo Royal National ENT and Eastman Dental Hospitalso University College Hospital Grafton Way Buildingo Royal London Hospital for Integrated Medicineo University College Hospital Macmillan Cancer Centreo The Hospital for Tropical Diseaseso University College Hospital at Westmoreland Street

We are dedicated to the diagnosis and treatment of many complex illnesses. UCLH specialises in women's health and the treatment of cancer, infection, neurological, gastrointestinal and oral disease. It has world class support services including critical care, imaging, nuclear medicine and pathology.

We are committed to sustainability and have pledged to become a carbon net zero health service, embedding sustainable practice throughout UCLH. We have set an ambitious target of net zero for our direct emissions by 2031 and indirect emissions by 2040.